Developing new methods to create complex organic molecules using metal catalysts
Metal catalysis in transformations of organic compounds
['FUNDING_OTHER'] · UNIVERSITY OF WASHINGTON · NIH-11089238
This study is exploring new ways to create important organic molecules that can help improve health and medicine, using special catalysts to make the process easier and more efficient.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11089238 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the synthesis of organic molecules, which are crucial for advancements in health and medicine. By utilizing transition-metal catalysts, the project aims to develop innovative catalytic transformations specifically for synthesizing alkenes from organoboron compounds. This approach seeks to overcome existing challenges in organic synthesis, such as improving the efficiency of cross-coupling reactions and controlling the structure of complex molecules. If successful, these new methods could significantly streamline the production of biologically important compounds.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new pharmaceuticals developed through advanced organic synthesis.
Not a fit: Patients who are not seeking new treatment options or those with conditions unrelated to the development of new organic compounds may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and effective methods for creating drugs and other important organic compounds.
How similar studies have performed: Other research in organic synthesis and catalysis has shown promising results, indicating that this approach has the potential for significant advancements.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LALIC, GOJKO — UNIVERSITY OF WASHINGTON
- Study coordinator: LALIC, GOJKO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.